A two‐drug combination simulation study for metastatic castrate resistant prostate cancer

BACKGROUND: Prostate cancer often evolves resistance to androgen deprivation therapy leading to a lethal metastatic castrate‐resistant form. Besides androgen independence, subpopulations of the tumor are genetically heterogeneous. With the advent of tumor genome sequencing we asked which has the gre...

Descripción completa

Detalles Bibliográficos
Autores principales: Root, Alex, Ebhardt, H. Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519289/
https://www.ncbi.nlm.nih.gov/pubmed/30027544
http://dx.doi.org/10.1002/pros.23694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519289/
https://www.ncbi.nlm.nih.gov/pubmed/30027544
http://dx.doi.org/10.1002/pros.23694

Ejemplares similares